Table 3.
Proportion of panel members rating each section of the Measure Card as ‘Very Important’ or ‘Extremely Important’*
| All Panel Members (n=70) | Clinical Researchers (n=32) | Clinicians/Professional Assoc. (n=19) | US Federal Research Funding Organizations (n=4) | Patients and Caregivers (n=15) | |
|---|---|---|---|---|---|
| Section 1: Number of questions | 42 (60) | 20 (63) | 13 (68) | 3 (75) | 6 (40) |
| Section 2: Description of instrument | 48 (69) | 22 (69) | 13 (68) | 4 (100) | 9 (60) |
| Section 3: Instrument versions | 14 (20) | 8 (25) | 4 (21) | 1 (25) | 1 (7) |
| Section 4: Recall period | 23 (33) | 12 (38) | 6 (32) | 2 (50) | 3 (20) |
| Section 5: Scoring information | 32 (46) | 14 (44) | 11 (58) | 2 (50) | 5 (33) |
| Section 6: Estimated time to complete | 58 (83) | 28 (88) | 17 (89) | 4 (100) | 9 (60) |
| Section 7: Administer to (e.g., patient, proxy) | 47 (67) | 22 (69) | 16 (84) | 3 (75) | 6 (40) |
| Section 8: Requires trained administrators | 49 (70) | 24 (75) | 17 (89) | 3 (75) | 5 (33) |
| Section 9: Mode of administration (e.g., in-person, phone) | 51 (73) | 28 (88) | 15 (79) | 3 (75) | 5 (33) |
| Section 10: Licensing fee information | 42 (60) | 21 (66) | 16 (84) | 3 (75) | 2 (13) |
| Section 11: Required equipment | 52 (74) | 27 (84) | 16 (84) | 4 (100) | 5 (33) |
| Section 12: Number of published critical care publications using instrument | 38 (54) | 19 (59) | 12 (63) | 4 (100) | 3 (20) |
| Section 13:Measurement properties of instrument and highest COSMIN rating | 44 (63) | 24 (75) | 14 (74) | 3 (75) | 3 (20) |
| Section 14: Online example | 26 (37) | 13 (41) | 6 (32) | 2 (50) | 5 (33) |
*
Response options were extremely important, very important, moderately important, slightly important, and not at all important